Spencer H. Kubo

7.8k total citations
90 papers, 4.9k citations indexed

About

Spencer H. Kubo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Spencer H. Kubo has authored 90 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Cardiology and Cardiovascular Medicine, 28 papers in Surgery and 20 papers in Complementary and alternative medicine. Recurrent topics in Spencer H. Kubo's work include Heart Failure Treatment and Management (28 papers), Cardiovascular and exercise physiology (20 papers) and Heart Rate Variability and Autonomic Control (20 papers). Spencer H. Kubo is often cited by papers focused on Heart Failure Treatment and Management (28 papers), Cardiovascular and exercise physiology (20 papers) and Heart Rate Variability and Autonomic Control (20 papers). Spencer H. Kubo collaborates with scholars based in United States, Canada and Australia. Spencer H. Kubo's co-authors include Thomas S. Rector, Robert Cody, Alan J. Bank, Jay N. Cohn, Douglas L. Mann, Mariell Jessup, Randall C. Starling, Paul Kligfield, Kathleen Mullen and Michael A. Acker and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Spencer H. Kubo

90 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Spencer H. Kubo United States 38 3.8k 1.4k 633 547 464 90 4.9k
Maria Teresa Olivari United States 17 3.0k 0.8× 643 0.4× 358 0.6× 385 0.7× 530 1.1× 31 3.8k
Alan J. Bank United States 37 3.7k 1.0× 1.1k 0.7× 748 1.2× 568 1.0× 578 1.2× 101 5.5k
Waldemar Banasiak Poland 40 4.7k 1.2× 631 0.4× 459 0.7× 914 1.7× 782 1.7× 173 7.9k
H.A.J. Struijker-Boudier Netherlands 13 4.5k 1.2× 663 0.5× 444 0.7× 1.2k 2.2× 207 0.4× 23 5.6k
Andrew D. Flapan United Kingdom 22 2.2k 0.6× 970 0.7× 411 0.6× 500 0.9× 256 0.6× 52 3.6k
Henry Dargie United Kingdom 20 3.5k 0.9× 870 0.6× 279 0.4× 405 0.7× 222 0.5× 48 4.7k
Michele Senni Italy 44 6.6k 1.7× 1.3k 0.9× 527 0.8× 1.1k 2.0× 326 0.7× 290 8.4k
Filippos Triposkiadis Greece 35 3.8k 1.0× 741 0.5× 353 0.6× 712 1.3× 221 0.5× 217 5.4k
P A Poole-Wilson United Kingdom 39 4.6k 1.2× 1.5k 1.0× 275 0.4× 630 1.2× 974 2.1× 78 6.7k
Mathias Rauchhaus Germany 36 4.1k 1.1× 1.3k 0.9× 392 0.6× 640 1.2× 422 0.9× 76 7.3k

Countries citing papers authored by Spencer H. Kubo

Since Specialization
Citations

This map shows the geographic impact of Spencer H. Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer H. Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer H. Kubo more than expected).

Fields of papers citing papers by Spencer H. Kubo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spencer H. Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer H. Kubo. The network helps show where Spencer H. Kubo may publish in the future.

Co-authorship network of co-authors of Spencer H. Kubo

This figure shows the co-authorship network connecting the top 25 collaborators of Spencer H. Kubo. A scholar is included among the top collaborators of Spencer H. Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spencer H. Kubo. Spencer H. Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Jagmeet P., Mary Norine Walsh, Spencer H. Kubo, et al.. (2021). Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial. American Heart Journal. 235. 158–162. 8 indexed citations
2.
Gold, Michael R., Dirk J. van Veldhuisen, Paul J. Hauptman, et al.. (2016). Vagus Nerve Stimulation for the Treatment of Heart Failure. Journal of the American College of Cardiology. 68(2). 149–158. 272 indexed citations
3.
Starling, Randall C., Mariell Jessup, Jae K. Oh, et al.. (2007). Sustained Benefits of the CorCap Cardiac Support Device on Left Ventricular Remodeling: Three Year Follow-up Results From the Acorn Clinical Trial. The Annals of Thoracic Surgery. 84(4). 1236–1242. 69 indexed citations
4.
Wu, Audrey H., Christie M. Ballantyne, Guillermo Torre‐Amione, et al.. (2005). Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. The American Journal of Cardiology. 95(3). 367–372. 32 indexed citations
5.
Livi, Ugolino, Ottavio Alfieri, Ettore Vitali, et al.. (2005). One-year clinical experience with the Acorn CorCap cardiac support device: results of a limited market release safety study in Italy and Sweden.. PubMed. 6(1). 59–65. 6 indexed citations
6.
Mann, Douglas L., Michael A. Acker, Mariell Jessup, et al.. (2004). Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure. Journal of Cardiac Failure. 10(3). 185–192. 40 indexed citations
7.
Kubo, Spencer H., et al.. (2004). Development and validation of a patient questionnaire to determine New York heart association classification. Journal of Cardiac Failure. 10(3). 228–235. 85 indexed citations
8.
Wilson, Robert F., et al.. (1996). Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure. Journal of Cardiac Failure. 2(1). 41–46. 35 indexed citations
9.
Kirlin, Philip C., Claude R. Benedict, Brent J. Shelton, et al.. (1995). Neurohumoral variability in left ventricular dysfunction. The American Journal of Cardiology. 75(5). 354–359. 8 indexed citations
10.
Johnson, Russell C., et al.. (1995). A Prospective Study of the Seroprevalence of Borrelia Burgdorferi Infection in Patients With Severe Heart Failure. The American Journal of Cardiology. 76(1-2). 97–100. 41 indexed citations
11.
Kubo, Spencer H., Thomas S. Rector, Alan J. Bank, et al.. (1994). Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. The American Journal of Cardiology. 74(11). 1133–1136. 51 indexed citations
12.
13.
Kubo, Spencer H., et al.. (1992). Factors influencing the development of hypercholesterolemia after cardiac transplantation. The American Journal of Cardiology. 70(4). 520–526. 19 indexed citations
14.
McGinn, Andrew L., Betsy V. Christensen, Susan M. Meyer, et al.. (1991). Nitroglycerin-induced coronary dilation is impaired early after cardiac transplantation. Journal of the American College of Cardiology. 17(2). A309–A309. 1 indexed citations
15.
Johnson, Thomas H., Kenneth McDonald, Raouf E. Nakhleh, et al.. (1991). Allograft vasculopathy and death in a cardiac transplant patient with angiographically normal coronary arteries. Catheterization and Cardiovascular Diagnosis. 24(1). 37–40. 4 indexed citations
16.
Fifer, Michael A., César Molina, Antonio C. Quiroz, et al.. (1990). Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. The American Journal of Cardiology. 65(3). 211–216. 58 indexed citations
17.
Francis, Gary S. & Spencer H. Kubo. (1989). Prognostic factors affecting diagnosis and treatment of congestive heart failure. Current Problems in Cardiology. 14(11). 625–671. 16 indexed citations
18.
Cody, Robert, K. Daniel Riew, & Spencer H. Kubo. (1989). Reversal of a calcium-mediated vasoconstrictor component in patients with congestive heart failure. Clinical Pharmacology & Therapeutics. 46(3). 291–296. 1 indexed citations
19.
Kubo, Spencer H., Maria Teresa Olivari, & Jay N. Cohn. (1988). Calcium Antagonists in Heart Failure. Annals of the New York Academy of Sciences. 522(1). 553–564. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Teresa Olivari Breakdown of academic impact, for papers by Alan J. Bank Breakdown of academic impact, for papers by Waldemar Banasiak Breakdown of academic impact, for papers by H.A.J. Struijker-Boudier Breakdown of academic impact, for papers by Andrew D. Flapan Breakdown of academic impact, for papers by Henry Dargie Breakdown of academic impact, for papers by Michele Senni Breakdown of academic impact, for papers by Filippos Triposkiadis Breakdown of academic impact, for papers by P A Poole-Wilson Breakdown of academic impact, for papers by Mathias Rauchhaus
Rankless by CCL
2026